A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants

Clinical trial NCT06547554 · COMPLETED

Trial details

NCT number: NCT06547554
Sponsor: Qpex Biopharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2024-09-04
Primary completion: 2025-10-27
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.